| Israël | Turquie | Espagne | |
| Thérapie CAR T | de $72,000 | de $150,000 | de $330,000 |
| Chimiothérapie pour le cancer du sein | de $22,500 | de $1,200 | de $3,500 |
| Chimiothérapie contre la leucémie | de $28,500 | de $8,000 | de $20,000 |
Spécialiste de premier plan des leucémies au centre médical Sourasky (Ichilov) – l'hôpital le plus grand et le plus avancé d'Israël.
Le Dr Ram a réalisé plusieurs centaines de greffes de cellules souches, un traitement fondamental de la leucémie, au centre médical Sourasky.
Chef de l'onco-hématologie pédiatrique à l'hôpital pour enfants Dana Dwek – Le Dr El Hasid se spécialise dans les greffes de moelle osseuse et de sang de cordon ombilical pour les enfants.
Dr. Arnon Nagler is an internationally recognized hematologist and bone marrow transplant expert. He is a Professor of Medicine at Tel Aviv University. He is Director Emeritus of Hematology & Bone Marrow Transplantation and the Cord Blood Bank at Sheba Medical Center. He earned his M.D. from the Hebrew University–Hadassah and an M.Sc. in hematopoiesis from Tel Aviv University. He completed postdoctoral training at Stanford. He is board certified in internal medicine and hematology.
He has more than 35 years of experience. He pioneered reduced‑intensity allogeneic transplant protocols for malignant and non‑malignant diseases. He founded Israel’s first public cord blood bank. He performed the country’s first cord blood transplants.
He has held international leadership roles. He served as Chair and Co‑Chair of the ALWP of the EBMT. He was a vice‑chair and long‑term member of EBMT committees. He served on the board of NetCord/EuroCord and as treasurer. He is a frequent invited speaker. He has published widely in journals such as Blood and Leukemia. He has led major clinical trials as a principal investigator and held editorial roles. He has received multiple awards for innovation and clinical excellence.